There are multiple major differences between our studies and the work by Floros et al. First, they were focused on targeting the redox balance of MYCN-amplified NB cells to induce ferroptosis, using different small molecule inhibitors such as buthionine-(S,R)-sulfoximine (BSO), sulfasalazine (SAS), and auranofin. Here, MYCN is linked to neuroblastoma.